Dublin, March 07, 2025 (GLOBE NEWSWIRE) — The “Animal Stem Cell Therapy Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The Animal Stem Cell Therapy Market was valued at USD 238.09 Million in 2024, and is expected to reach USD 338.71 Million by 2030, rising at a CAGR of 6.01%. The global market is benefiting from robust growth driven by rising pet ownership and increased spending on animal healthcare.
Over 50% of the global population is estimated to own pets, with households in the U.S., EU, and China collectively hosting more than 500 million dogs and cats. In the U.S., pet ownership has steadily increased, from 68% of households in 2016 to 70% in 2021, reflecting the growing importance of pets in family life. This trend presents substantial opportunities for industries focused on pet care, nutrition, and related services. Consumers are increasingly prioritizing pet-related products and services, particularly in advanced veterinary treatments such as stem cell therapy.
The pet ownership trend continues to rise, especially in developed regions like North America, Europe, and parts of Asia-Pacific. Younger generations, including Millennials and Gen Z, are particularly likely to adopt pets as companions. A survey indicates that 45% of Gen Z and 40% of Millennials consider their pets the most important part of their lives, underlining a significant emotional and financial investment in pet care. In contrast, only 29% of older generations share this perspective, highlighting a generational shift in consumer behavior and spending patterns within the pet care industry.
Additionally, pets are increasingly seen as sources of emotional support, contributing to a growing demand for quality healthcare services. In the Asia-Pacific region, particularly in China, the pet humanization trend is on the rise, with 55% of pet owners considering their pets as children, and 28% regarding them as family members.
Key Market Challenge: Safety and Efficacy Concerns
Ensuring the safety and efficacy of stem cell therapies for animals remains a critical challenge. Although these therapies show significant promise, further research and clinical trials are necessary to establish their long-term safety and effectiveness for various medical conditions across different animal species.
Key Players Profiled in the Animal Stem Cell Therapy Market
- Ardent Animal Health
- Vet Stem Inc.
- Medrego
- Vetbiologics
- VETHERAPY
- Celavie Biosciences
- Magellan Stem Cells
- Animal General
- Animal Cell Therapies, Inc.
- Cell Therapy Sciences Ltd.
Report Scope
By Type
- Dogs Stem Cell Therapy
- Horses Stem Cell Therapy
By Application
- Veterinary Hospitals
- Research Organizations
By Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Key Attributes
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $238.09 Million |
| Forecasted Market Value (USD) by 2030 | $338.71 Million |
| Compound Annual Growth Rate | 6% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/d5f549
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Animal Stem Cell Therapy Market
